HPC, Cord Blood
| Brand name | Clevecord |
|---|---|
| Active ingredient | HPC, Cord Blood |
| Strength | 5 x 10^8 TOTAL NUCLEATED CELLS WITH AT LEAST 1.25 x 106 VIABLE CD34+ CELLS |
| Dosage form | Injection |
| Route | Intravenous |
| Modality | Biologic |
| FDA approval | September 2016 |
| Marketing status | Rx |
Source: FDA Purple Book, layered on the CliffBio company graph. Cliff dates are the projected — 12-year biologic exclusivity estimate; estimates are projections, not legal advice.